Abstract
Real-World Utilization of Fedratinib for Myelofibrosis Post-Ruxolitinib: Patient Characteristics, Treatment Patterns, and Characterization of Ruxolitinib Failure
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have